Safety, tolerability, and pharmacokinetics of an anti-LAG-3 antibody SHR-1802 in patients with advanced solid tumors: a phase I dose-escalation and dose-expansion study - Concepedia

Concepedia

Publication | Open Access

Safety, tolerability, and pharmacokinetics of an anti-LAG-3 antibody SHR-1802 in patients with advanced solid tumors: a phase I dose-escalation and dose-expansion study

DOI Full Paper Access

19

Citations

18

References

2023

Year

Ting Deng, Zhigang Liu, Zhengquan Han, Huan Zhou, Rui Liu, Yijing Li, Shaorong Li, Peng Xiu, Shuni Wang, Yiping Zhang,

Therapeutic Advances in Medical Oncology

Abstract

NCT04414150.

References

	Year	Citations

Page 1